by Urea breath test is a non-invasive diagnostic procedure used to detect the presence of Helicobacter pylori (H. pylori) bacteria in the stomach and duodenum. It involves administering non-radioactive C-13 or C-14 labeled urea to the patient and measuring the amount of C-13 or C-14 labeled CO2 in the breath. The global urea breath test market offers advantages such as ease of use, accurate results and non-invasive nature. Rise in prevalence of stomach infections and increasing adoption of minimally invasive diagnostic procedures are driving the need for urea breath tests.
The global Urea Breath Test Market is estimated to be valued at US$ 140.8 Mn in 2023 and is expected to exhibit a CAGR of 6.6% over the forecast period 2024 to 2031, as highlighted in a new report published by Coherent Market Insights.
Market key trends:
The urea breath test market is expected to witness significant growth over the forecast period owing to the rising incidence of Helicobacter pylori infections. According to the World Gastroenterology Organisation, around 35% of the global population is infected with H. pylori. The increasingdiagnosis of H. pylori infection cases due to wide accessibility and affordability of diagnostic tests in developed nations supplement the growth of the market. Furthermore, the non-invasive nature and higher accuracy of urea breath tests compared to invasive endoscopy or stool antigen tests drive their increased adoption.
SWOT Analysis
Strength: The urea breath test market has strong growth potential due to rising awareness about Helicobacter pylori (H. pylori) infection diagnosis. It is a non-invasive diagnostic method for detecting H. pylori with high accuracy levels.
Weakness: High costs associated with urea breath test instruments can be a constraint for widespread adoption. Interpreting test results also requires skilled medical professionals.
Opportunity: Growing geriatric population prone to gastric ailments creates opportunities for market players. Technological advances improving ease of use and affordability of urea breath test kits will boost the market.
Threats: Alternative diagnostic methods like stool antigen tests and blood serology pose competition in some regions. Lack of awareness in developing regions challenges market growth.
Key Takeaways
The Global Urea Breath Test Market Size is expected to witness high growth over the forecast period from 2024 to 2031. The market size for 2024 is estimated at US$ 140.8 million and projected to expand at a CAGR of 6.6% through 2031.
Regional analysis: North America dominates currently owing to advanced healthcare facilities and rising H. pylori infection incidence. However, Asia Pacific islikely to emerge as the fastest growing regional market. Factors such as improving access to healthcare and increasing awareness among rapidly expanding populations will drive market gains.
Key players: Key players operating in the urea breath test market are Al Dahra ACX Global Inc., Alfalfa Monegros SL, Green Prairie International, and Riverina (Australia) Pty Ltd. They are focusing on new product launches, geographic expansions, and partnerships with medical facilities to strengthen their market positions. For example, Al Dahra ACX Global Inc. offers a wide range of urea breath test kits tailored for specific user needs with high accuracy and ease of use.
*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it
